Yesterday, the President & CEO of Invitae (NVTA), Sean George, sold shares of NVTA for $137.4K.
In addition to Sean George, 5 other NVTA executives reported Sell trades in the last month.
See today’s analyst top recommended stocks >>
Based on Invitae’s latest earnings report for the quarter ending December 31, the company posted quarterly revenue of $66.29 million and GAAP net loss of $76.91 million. In comparison, last year the company earned revenue of $45.36 million and had a GAAP net loss of $29.84 million. The company has a one-year high of $28.75 and a one-year low of $9.75.
Company insider trades’ information is brought to you by the DailyInsider, a proprietary algorithm that analyzes insider trading activity to detect the most attractive trading opportunities. To subscribe to the DailyInsider visit this page.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Invitae Corp. engages in the provision of genetic information into mainstream medical practice. It includes comprehensive panels for hereditary conditions in cancer, cardiology, neurology, pediatric, and rare diseases. The company was founded by Randal W. Scott and Sean E. George on January 13, 2010 and is headquartered in San Francisco, CA.